The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria

被引:1
作者
Diaz Vera, Alcibiades Segundo [1 ]
Abellan Aleman, Jose [2 ]
Segura Fragoso, Antonio [3 ]
Martinez de Esteban, Juan Pablo [4 ]
Lameiro Couso, Francisco Javier [5 ]
Golac Rabanal, Miladi del Socorro [6 ]
Diaz Vera, Luis Alberto [7 ]
Matta Solis, Hernan Hugo [8 ]
机构
[1] Univ Catolica San Antonio Murcia, Programa Doctorado Ciencias Salud, Murcia, Spain
[2] Univ Catolica San Antonio Murcia, Catedra Riesgo Cardiovasc, Murcia, Spain
[3] Univ Castilla La Mancha, Inst Ciencias Salud, Serv Invest, Talavera Reina Toledo, Talavera De La Reina, Toledo, Spain
[4] Hosp Garcia Orcoyen, Endocrinol & Nutr, Estella, Navarra, Spain
[5] Hosp Garcia Orcoyen, Med Prevent, Estella, Navarra, Spain
[6] Univ San Jorge, Enfermeria, Zaragoza, Aragon, Spain
[7] Hosp Edgardo Rebagliati Martins, Ginecol & Obstet, Lima, Peru
[8] Univ Ciencias & Humanidades, Lima, Peru
来源
ENDOCRINOLOGIA DIABETES Y NUTRICION | 2020年 / 67卷 / 02期
关键词
Dystipidemia; Type 2 diabetes mellitus; Prevalence; Risk factors; CARDIOVASCULAR-DISEASE; SPANISH SOCIETY; MELLITUS; CARE;
D O I
10.1016/J.endinu.2019.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Dystipidemia is one of the main risk factors in cardiovascular disease in patients with diabetes mellitus type 2 (DM2). The aim of this study is to evaluate the prevalence and risk factors associated with dyslipidemia in the population with diabetes mellitus type 2 in the region of Cantabria. Material and methods: This is a transversal study carried out at Cantabrian primary health care centres (n=680). A representative, random sample of the population with DM2, ranging from 18-85, was selected using a multistage procedure. The medical records were obtained, and by means of interviews the data of the risk factors to be studied was secured. The correlation with dyslipidemia was analysed by means of logistic regression. Results: There were 52.1% of males, the average age was 69.8, the evolution of diabetes was 9.99 years, 84.3% had arterial hypertension, 76.6% were overweight or obese and the average HbA1c was 6.96%. The prevalence of dyslipidemia was 85.3%, and in the bivariate analysis this is associated with a history of peripheral artery disease, controlled diabetes, antihypertensive treatment, glomerular filtration, HbA1c>7%, body fat estimated as being either overweight or obese, a history of cardiovascular disease, age and HbA1c. In the multivariate analysis the independent factors were being female and a history of cardiovascular disease. Conclusion: The prevalence of dyslipidemia in our study was 85.3%, and is consistent with figures found in previous published studies. The independent associated risk factors were being female and a past medical history of cardiovascular disease. (C) 2019 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:102 / 112
页数:11
相关论文
共 30 条
[1]  
American Diabetes Association, 2017, Diabetes Care, V40, pS88
[2]  
[Anonymous], ESP NUM MUERT DIAB
[3]  
[Anonymous], REV CLIN MED FAM
[4]  
[Anonymous], REV ESP CARDIOL S
[5]  
[Anonymous], REV ESP CARDIOL
[6]  
[Anonymous], REV ESPANOLA CARDIOL
[7]   Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015) [J].
Arrieta, Francisco ;
Iglesias, Pedro ;
Pedro-Botet, Juan ;
Javier Tebar, Francisco ;
Ortega, Emilio ;
Nubiola, Andreu ;
Luis Pardo, Jose ;
Fernando Maldonado, Gonzalo ;
Carlos Obaya, Juan ;
Matute, Pablo ;
Petrecca, Romina ;
Alonso, Nuria ;
Sarabia, Elena ;
Sanchez-Margalet, Victor ;
Juan Aleman, Jose ;
Navarro, Jorge ;
Becerra, Antonio ;
Duran, Santiago ;
Aguilar, Manuel ;
Escobar-Jimenez, Fernando .
ATENCION PRIMARIA, 2016, 48 (05) :325-336
[8]  
Catapano Alberico L, 2017, Rev Esp Cardiol (Engl Ed), V70, P115, DOI 10.1016/j.rec.2017.01.002
[9]   Direct cost of diabetes mellitus and its complications in Spain (SECCAID Study: Spain estimated cost Ciberdem-Cabimer in Diabetes) [J].
Crespo, Carlos ;
Brosa, Max ;
Soria-Juan, Aitana ;
Lopez-Alba, Alfonso ;
Lopez-Martinez, Noemi ;
Soria, Bernat .
AVANCES EN DIABETOLOGIA, 2013, 29 (06) :182-189
[10]  
Daya R, 2017, JEMDSA, V22, P31, DOI 10.1080/16089677.2017.1360064